Literature DB >> 36273129

Identification of a novel pathogenic TBCK variant in a Chinese patient with infantile hypotonia with psychomotor retardation and characteristic facies type 3 (IHPRF3): a case report.

Hao-Yi Tan1, Bin Wang2, Yuan-Zong Song3.   

Abstract

BACKGROUND: Infantile hypotonia with psychomotor retardation and characteristic facies type 3(IHPRF3) (OMIM #616,900) is an autosomal recessive disorder caused by biallelic pathogenic variants of the TBCK gene, and to date, this disease was reported rather limitedly in number and all described cases were Caucasians. CASE
PRESENTATION: This paper reported the clinical and genetic features of a Chinese patient with IHPRF3. The patient was a 15-month-old male with global developmental delay, profound hypotonia, and typical facial dysmorphic features including mildly coarse facial appearance, hypertelorism, tented upper lip, exaggerated Cupid's bow, macroglossia and arched eyebrows. Magnetic Resonance Imaging (MRI) analysis of the brain revealed slightly widened bilateral ventricles and subarachnoid space. On genetic analysis, the patient was homozygous for a novel TBCK variant c.247C > T(p.Arg83Ter). The parents were both carriers without any positive symptoms or signs. With an extremely low frequency (0.0000082) in Exome Aggregation Consortium, the variant has not been reported in any other databases or official literatures, and was diagnosed to be pathogenic according to the American College of Medical Genetics and Genomics(ACMG) standards and guidelines. Neurorehabilitation training did not work well and the long-term prognosis remained to be observed.
CONCLUSIONS: This study reported the clinical and molecular features of the first non-Caucasian patient with IHPRF3 arising from a novel homozygous TBCK mutation, which provided a novel molecular marker for the definite diagnosis of IHPRF3 patients and for its genetic counseling and prenatal diagnosis in the affected families.
© 2022. The Author(s).

Entities:  

Keywords:  Child; Genetic mutation; Hypotonia; IHPRF3; TBCK

Year:  2022        PMID: 36273129     DOI: 10.1186/s12887-022-03672-w

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.567


  12 in total

1.  A familial dysmorphic condition with hypotonia, seizures and precocious puberty.

Authors:  Audrey Smith; Kathryn Leask; Pamela Tomlin; Dian Donnai
Journal:  Clin Dysmorphol       Date:  2008-07       Impact factor: 0.816

2.  Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families.

Authors:  Anas M Alazami; Nisha Patel; Hanan E Shamseldin; Shamsa Anazi; Mohammed S Al-Dosari; Fatema Alzahrani; Hadia Hijazi; Muneera Alshammari; Mohammed A Aldahmesh; Mustafa A Salih; Eissa Faqeih; Amal Alhashem; Fahad A Bashiri; Mohammed Al-Owain; Amal Y Kentab; Sameera Sogaty; Saeed Al Tala; Mohamad-Hani Temsah; Maha Tulbah; Rasha F Aljelaify; Saad A Alshahwan; Mohammed Zain Seidahmed; Adnan A Alhadid; Hesham Aldhalaan; Fatema AlQallaf; Wesam Kurdi; Majid Alfadhel; Zainab Babay; Mohammad Alsogheer; Namik Kaya; Zuhair N Al-Hassnan; Ghada M H Abdel-Salam; Nouriya Al-Sannaa; Fuad Al Mutairi; Heba Y El Khashab; Saeed Bohlega; Xiaofei Jia; Henry C Nguyen; Rakad Hammami; Nouran Adly; Jawahir Y Mohamed; Firdous Abdulwahab; Niema Ibrahim; Ewa A Naim; Banan Al-Younes; Brian F Meyer; Mais Hashem; Ranad Shaheen; Yong Xiong; Mohamed Abouelhoda; Abdulrahman A Aldeeri; Dorota M Monies; Fowzan S Alkuraya
Journal:  Cell Rep       Date:  2014-12-31       Impact factor: 9.423

3.  A long type of TBCK is a novel cytoplasmic and mitotic apparatus-associated protein likely suppressing cell proliferation.

Authors:  Jin Wu; Qianyi Li; Yan Li; Jing Lin; Dong Yang; Guixin Zhu; Limin Wang; Dacheng He; Guanting Lu; Changqing Zeng
Journal:  J Genet Genomics       Date:  2014-01-04       Impact factor: 4.275

4.  TBCK-related intellectual disability syndrome: Case study of two patients.

Authors:  Hanna Mandel; Morad Khayat; Elana Chervinsky; Orly Elpeleg; Stavit Shalev
Journal:  Am J Med Genet A       Date:  2016-10-17       Impact factor: 2.802

5.  Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.

Authors:  Smita Saxena; Francesco Roselli; Katyayani Singh; Kerstin Leptien; Jean-Pierre Julien; Francois Gros-Louis; Pico Caroni
Journal:  Neuron       Date:  2013-10-02       Impact factor: 17.173

6.  Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and Hypotonia.

Authors:  Elizabeth J Bhoj; Dong Li; Margaret Harr; Shimon Edvardson; Orly Elpeleg; Elizabeth Chisholm; Jane Juusola; Ganka Douglas; Maria J Guillen Sacoto; Karine Siquier-Pernet; Abdelkrim Saadi; Christine Bole-Feysot; Patrick Nitschke; Alekhya Narravula; Maria Walke; Michele B Horner; Debra-Lynn Day-Salvatore; Parul Jayakar; Samantha A Schrier Vergano; Mark A Tarnopolsky; Madhuri Hegde; Laurence Colleaux; Peter Crino; Hakon Hakonarson
Journal:  Am J Hum Genet       Date:  2016-03-31       Impact factor: 11.025

Review 7.  Further delineation of TBCK - Infantile hypotonia with psychomotor retardation and characteristic facies type 3.

Authors:  Eugenio Zapata-Aldana; David Dongkyung Kim; Salma Remtulla; Chitra Prasad; Cam-Tu Nguyen; Craig Campbell
Journal:  Eur J Med Genet       Date:  2018-08-11       Impact factor: 2.708

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Mutation of TBCK causes a rare recessive developmental disorder.

Authors:  Rita J Guerreiro; Rachel Brown; Donnai Dian; Christian de Goede; Jose Bras; Sara E Mole
Journal:  Neurol Genet       Date:  2016-05-24

10.  TBCK influences cell proliferation, cell size and mTOR signaling pathway.

Authors:  Yueli Liu; Xiaoyi Yan; Tianhua Zhou
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.